 Jay Vivian
Concepts (274)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Animals | 34 | 2024 | 563 | 1.780 |
Why?
| | Mice | 24 | 2023 | 290 | 1.320 |
Why?
| | Embryonic Stem Cells | 5 | 2013 | 7 | 1.270 |
Why?
| | Cell Differentiation | 8 | 2021 | 41 | 1.070 |
Why?
| | Embryonic Development | 3 | 2020 | 4 | 1.000 |
Why?
| | Signal Transduction | 6 | 2018 | 107 | 0.990 |
Why?
| | Animals, Laboratory | 1 | 2023 | 2 | 0.950 |
Why?
| | Trophoblasts | 4 | 2024 | 15 | 0.950 |
Why?
| | Transforming Growth Factor beta | 3 | 2013 | 10 | 0.950 |
Why?
| | Nodal Protein | 3 | 2013 | 3 | 0.930 |
Why?
| | Mitochondria | 1 | 2023 | 9 | 0.910 |
Why?
| | Pluripotent Stem Cells | 4 | 2014 | 5 | 0.780 |
Why?
| | Blastocyst | 2 | 2020 | 2 | 0.770 |
Why?
| | Neoplasms | 1 | 2023 | 119 | 0.760 |
Why?
| | Sendai virus | 1 | 2020 | 1 | 0.740 |
Why?
| | Primary Cell Culture | 1 | 2020 | 5 | 0.740 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2020 | 2 | 0.740 |
Why?
| | Cell Culture Techniques | 1 | 2020 | 5 | 0.740 |
Why?
| | CRISPR-Cas Systems | 1 | 2020 | 13 | 0.730 |
Why?
| | Myogenin | 5 | 2000 | 5 | 0.620 |
Why?
| | Bone Morphogenetic Proteins | 2 | 2013 | 7 | 0.550 |
Why?
| | Jaundice | 3 | 2022 | 4 | 0.530 |
Why?
| | Neural Stem Cells | 3 | 2022 | 5 | 0.530 |
Why?
| | Placentation | 3 | 2024 | 15 | 0.470 |
Why?
| | Placenta | 3 | 2024 | 19 | 0.440 |
Why?
| | Yolk Sac | 2 | 2011 | 2 | 0.430 |
Why?
| | Cell Lineage | 4 | 2024 | 17 | 0.410 |
Why?
| | Receptors, Notch | 1 | 2011 | 3 | 0.400 |
Why?
| | Blood Vessels | 1 | 2011 | 5 | 0.400 |
Why?
| | Polycystic Kidney, Autosomal Dominant | 2 | 2022 | 2 | 0.390 |
Why?
| | Kidney Tubules, Collecting | 2 | 2022 | 3 | 0.390 |
Why?
| | Pregnancy | 7 | 2024 | 203 | 0.380 |
Why?
| | Bone Morphogenetic Protein 4 | 1 | 2010 | 1 | 0.380 |
Why?
| | Rats | 9 | 2024 | 97 | 0.360 |
Why?
| | Mice, Transgenic | 8 | 2023 | 33 | 0.340 |
Why?
| | Female | 15 | 2024 | 3436 | 0.330 |
Why?
| | Humans | 13 | 2024 | 6599 | 0.320 |
Why?
| | Prolactin | 2 | 2017 | 2 | 0.300 |
Why?
| | Cell Proliferation | 3 | 2018 | 55 | 0.300 |
Why?
| | Stem Cells | 4 | 2021 | 19 | 0.290 |
Why?
| | Transcription Factors | 3 | 2015 | 46 | 0.290 |
Why?
| | Gene Expression Regulation, Developmental | 6 | 2015 | 33 | 0.280 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 2 | 2021 | 13 | 0.280 |
Why?
| | Infertility, Female | 2 | 2017 | 2 | 0.280 |
Why?
| | Homeodomain Proteins | 3 | 2014 | 18 | 0.270 |
Why?
| | Gene Expression Regulation | 3 | 2018 | 98 | 0.270 |
Why?
| | Muscle, Skeletal | 3 | 1999 | 11 | 0.260 |
Why?
| | Mice, Knockout | 6 | 2020 | 54 | 0.260 |
Why?
| | Cell Nucleus | 2 | 2023 | 6 | 0.260 |
Why?
| | DNA-Binding Proteins | 2 | 2015 | 35 | 0.240 |
Why?
| | Histone-Lysine N-Methyltransferase | 2 | 2022 | 9 | 0.240 |
Why?
| | Rosa | 1 | 2023 | 1 | 0.240 |
Why?
| | Mutation | 6 | 2016 | 194 | 0.240 |
Why?
| | DNA, Mitochondrial | 1 | 2023 | 5 | 0.230 |
Why?
| | Reactive Oxygen Species | 1 | 2023 | 6 | 0.230 |
Why?
| | Male | 9 | 2023 | 3197 | 0.230 |
Why?
| | Autocrine Communication | 2 | 2014 | 2 | 0.220 |
Why?
| | Sternum | 2 | 2000 | 6 | 0.220 |
Why?
| | Polycystic Kidney, Autosomal Recessive | 1 | 2022 | 5 | 0.220 |
Why?
| | Cysts | 1 | 2022 | 4 | 0.220 |
Why?
| | Polymorphism, Genetic | 1 | 2023 | 89 | 0.220 |
Why?
| | Zygote | 2 | 2020 | 2 | 0.220 |
Why?
| | Erythropoietin | 1 | 2022 | 18 | 0.220 |
Why?
| | Calcium | 1 | 2022 | 36 | 0.210 |
Why?
| | Kernicterus | 1 | 2022 | 7 | 0.210 |
Why?
| | Benzamides | 2 | 2013 | 2 | 0.210 |
Why?
| | Smad7 Protein | 2 | 2013 | 2 | 0.210 |
Why?
| | Dystonia | 1 | 2022 | 7 | 0.210 |
Why?
| | Phosphorylation | 2 | 2013 | 21 | 0.210 |
Why?
| | Fibroblasts | 2 | 2020 | 26 | 0.200 |
Why?
| | Phenotype | 4 | 2018 | 233 | 0.190 |
Why?
| | Intercostal Muscles | 1 | 2000 | 1 | 0.190 |
Why?
| | Myogenic Regulatory Factors | 1 | 2000 | 1 | 0.190 |
Why?
| | Somites | 1 | 2000 | 1 | 0.190 |
Why?
| | Thorax | 1 | 2000 | 4 | 0.190 |
Why?
| | Cilia | 1 | 2020 | 1 | 0.190 |
Why?
| | Flagella | 1 | 2020 | 1 | 0.190 |
Why?
| | Hedgehog Proteins | 1 | 2020 | 5 | 0.190 |
Why?
| | Mice, Inbred C57BL | 5 | 2020 | 76 | 0.190 |
Why?
| | Cells, Cultured | 4 | 2018 | 73 | 0.190 |
Why?
| | Cellular Reprogramming | 1 | 2020 | 1 | 0.190 |
Why?
| | Membrane Proteins | 1 | 2020 | 50 | 0.180 |
Why?
| | Gonadotropins | 2 | 2017 | 3 | 0.180 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2020 | 34 | 0.180 |
Why?
| | Gene Targeting | 1 | 1999 | 5 | 0.180 |
Why?
| | Lac Operon | 1 | 1999 | 2 | 0.180 |
Why?
| | Hypoxanthine Phosphoribosyltransferase | 1 | 1999 | 2 | 0.180 |
Why?
| | Cell Adhesion Molecules | 2 | 2018 | 4 | 0.180 |
Why?
| | RNA, Messenger | 4 | 2014 | 107 | 0.180 |
Why?
| | Muscle Development | 1 | 1999 | 1 | 0.180 |
Why?
| | Epithelial Cells | 1 | 2018 | 3 | 0.170 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2015 | 64 | 0.170 |
Why?
| | Median Eminence | 1 | 2018 | 1 | 0.170 |
Why?
| | Muscle Proteins | 3 | 2012 | 6 | 0.160 |
Why?
| | Estrogen Receptor beta | 1 | 2017 | 1 | 0.160 |
Why?
| | Fertility | 1 | 2017 | 15 | 0.150 |
Why?
| | Glycoproteins | 1 | 2017 | 9 | 0.150 |
Why?
| | Testis | 1 | 2017 | 7 | 0.150 |
Why?
| | Embryo, Mammalian | 2 | 2010 | 5 | 0.150 |
Why?
| | Rats, Sprague-Dawley | 4 | 2021 | 46 | 0.150 |
Why?
| | Erythropoiesis | 2 | 2022 | 3 | 0.150 |
Why?
| | Progesterone | 1 | 2016 | 2 | 0.140 |
Why?
| | Adaptation, Physiological | 1 | 2016 | 4 | 0.140 |
Why?
| | Brain | 1 | 2017 | 74 | 0.140 |
Why?
| | Reproduction | 1 | 2016 | 7 | 0.140 |
Why?
| | Stress, Physiological | 1 | 2016 | 6 | 0.140 |
Why?
| | Base Sequence | 3 | 2015 | 76 | 0.140 |
Why?
| | Protein Isoforms | 2 | 2017 | 16 | 0.140 |
Why?
| | Transcription, Genetic | 2 | 2013 | 44 | 0.140 |
Why?
| | Microarray Analysis | 2 | 2015 | 6 | 0.140 |
Why?
| | Fluorescent Antibody Technique | 2 | 2015 | 8 | 0.130 |
Why?
| | Rats, Gunn | 3 | 2022 | 4 | 0.130 |
Why?
| | Cell Line | 2 | 2013 | 80 | 0.130 |
Why?
| | Fibroblast Growth Factors | 1 | 2014 | 27 | 0.130 |
Why?
| | Models, Biological | 1 | 2014 | 46 | 0.120 |
Why?
| | Infertility, Male | 1 | 2014 | 1 | 0.120 |
Why?
| | Estrogen Receptor alpha | 1 | 2014 | 7 | 0.120 |
Why?
| | RNA Interference | 2 | 2012 | 15 | 0.120 |
Why?
| | Diphenylamine | 1 | 2013 | 1 | 0.110 |
Why?
| | Fibroblast Growth Factor 4 | 1 | 2013 | 1 | 0.110 |
Why?
| | MAP Kinase Kinase 1 | 1 | 2013 | 2 | 0.110 |
Why?
| | Gene Expression | 2 | 2010 | 60 | 0.100 |
Why?
| | Endothelium | 1 | 2011 | 1 | 0.100 |
Why?
| | Extraembryonic Membranes | 1 | 2011 | 1 | 0.100 |
Why?
| | Fetal Development | 1 | 2011 | 4 | 0.100 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2011 | 5 | 0.100 |
Why?
| | Gene Silencing | 1 | 2011 | 13 | 0.100 |
Why?
| | Receptors, Cell Surface | 2 | 2022 | 6 | 0.100 |
Why?
| | Fibrosis | 2 | 2022 | 4 | 0.100 |
Why?
| | Polymerase Chain Reaction | 1 | 2011 | 82 | 0.100 |
Why?
| | Methyltransferases | 1 | 2010 | 9 | 0.100 |
Why?
| | Gene Expression Profiling | 1 | 2011 | 109 | 0.090 |
Why?
| | Dioxoles | 1 | 2010 | 1 | 0.090 |
Why?
| | Smad1 Protein | 1 | 2010 | 1 | 0.090 |
Why?
| | Smad5 Protein | 1 | 2010 | 1 | 0.090 |
Why?
| | Left-Right Determination Factors | 1 | 2010 | 1 | 0.090 |
Why?
| | Smad2 Protein | 1 | 2010 | 2 | 0.090 |
Why?
| | Parvalbumins | 2 | 2022 | 2 | 0.090 |
Why?
| | Immunoblotting | 1 | 2010 | 11 | 0.090 |
Why?
| | In Situ Hybridization | 3 | 2015 | 8 | 0.090 |
Why?
| | Time Factors | 3 | 2018 | 241 | 0.090 |
Why?
| | Genotype | 1 | 2011 | 395 | 0.090 |
Why?
| | Immunohistochemistry | 3 | 2015 | 36 | 0.090 |
Why?
| | Alleles | 2 | 2000 | 197 | 0.080 |
Why?
| | Vascular Endothelial Growth Factor Receptor-1 | 1 | 2008 | 1 | 0.080 |
Why?
| | Proto-Oncogene Protein c-ets-1 | 1 | 2008 | 1 | 0.080 |
Why?
| | Neovascularization, Pathologic | 1 | 2008 | 6 | 0.080 |
Why?
| | Chromatin | 1 | 2008 | 20 | 0.080 |
Why?
| | Blotting, Western | 3 | 2015 | 16 | 0.080 |
Why?
| | Crosses, Genetic | 2 | 2014 | 4 | 0.080 |
Why?
| | Cell Survival | 2 | 2018 | 19 | 0.080 |
Why?
| | Protein Biosynthesis | 1 | 2007 | 2 | 0.080 |
Why?
| | Ribosomal Proteins | 1 | 2007 | 4 | 0.080 |
Why?
| | Growth | 1 | 2007 | 9 | 0.080 |
Why?
| | Pilot Projects | 2 | 2023 | 124 | 0.070 |
Why?
| | Rats, Transgenic | 2 | 2017 | 3 | 0.070 |
Why?
| | Exons | 2 | 2016 | 32 | 0.070 |
Why?
| | HEK293 Cells | 2 | 2017 | 30 | 0.070 |
Why?
| | Sequence Analysis, RNA | 2 | 2015 | 23 | 0.070 |
Why?
| | Models, Animal | 1 | 2024 | 6 | 0.060 |
Why?
| | Uterus | 1 | 2024 | 8 | 0.060 |
Why?
| | Plant Breeding | 1 | 2023 | 1 | 0.060 |
Why?
| | Aromatase | 1 | 2023 | 4 | 0.060 |
Why?
| | Mosaicism | 1 | 2023 | 8 | 0.060 |
Why?
| | Mutagenesis | 1 | 2003 | 4 | 0.060 |
Why?
| | Genetic Techniques | 1 | 2003 | 5 | 0.060 |
Why?
| | Desmin | 2 | 2000 | 2 | 0.060 |
Why?
| | Capsaicin | 1 | 2002 | 1 | 0.060 |
Why?
| | Hematuria | 1 | 2002 | 7 | 0.060 |
Why?
| | Arginine Vasopressin | 1 | 2022 | 1 | 0.060 |
Why?
| | Proliferating Cell Nuclear Antigen | 1 | 2022 | 2 | 0.060 |
Why?
| | Proto-Oncogenes | 1 | 2022 | 2 | 0.060 |
Why?
| | Cyclic AMP | 1 | 2022 | 4 | 0.060 |
Why?
| | Proto-Oncogene Proteins B-raf | 1 | 2022 | 3 | 0.060 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2022 | 4 | 0.060 |
Why?
| | Receptors, Erythropoietin | 1 | 2022 | 1 | 0.050 |
Why?
| | TRPC Cation Channels | 1 | 2022 | 1 | 0.050 |
Why?
| | Erythroid Precursor Cells | 1 | 2022 | 2 | 0.050 |
Why?
| | Epoetin Alfa | 1 | 2022 | 3 | 0.050 |
Why?
| | Calcium, Dietary | 1 | 2022 | 7 | 0.050 |
Why?
| | Pain | 1 | 2002 | 53 | 0.050 |
Why?
| | Enkephalins | 1 | 2022 | 1 | 0.050 |
Why?
| | Protein Precursors | 1 | 2022 | 1 | 0.050 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2022 | 2 | 0.050 |
Why?
| | Ribs | 1 | 2000 | 6 | 0.050 |
Why?
| | Protein Transport | 1 | 2020 | 5 | 0.050 |
Why?
| | Histones | 2 | 2010 | 15 | 0.040 |
Why?
| | Arabinofuranosyluracil | 1 | 1999 | 1 | 0.040 |
Why?
| | X Chromosome | 1 | 1999 | 1 | 0.040 |
Why?
| | Histocytochemistry | 1 | 1999 | 4 | 0.040 |
Why?
| | Thymidine Kinase | 1 | 1999 | 2 | 0.040 |
Why?
| | Herpesvirus 1, Human | 1 | 1999 | 4 | 0.040 |
Why?
| | Helix-Loop-Helix Motifs | 1 | 1999 | 2 | 0.040 |
Why?
| | Embryonic and Fetal Development | 1 | 1999 | 5 | 0.040 |
Why?
| | Promoter Regions, Genetic | 1 | 1999 | 47 | 0.040 |
Why?
| | Gene Dosage | 1 | 1999 | 8 | 0.040 |
Why?
| | Extracellular Matrix | 1 | 2018 | 2 | 0.040 |
Why?
| | Molecular Sequence Data | 2 | 2015 | 65 | 0.040 |
Why?
| | Up-Regulation | 1 | 2018 | 25 | 0.040 |
Why?
| | Adult | 2 | 2018 | 1233 | 0.040 |
Why?
| | Cell Movement | 1 | 2018 | 21 | 0.040 |
Why?
| | Disease Models, Animal | 1 | 2018 | 55 | 0.040 |
Why?
| | Human Embryonic Stem Cells | 1 | 2018 | 1 | 0.040 |
Why?
| | Disease Progression | 1 | 2018 | 104 | 0.040 |
Why?
| | Bilirubin | 1 | 2018 | 25 | 0.040 |
Why?
| | Case-Control Studies | 1 | 2018 | 202 | 0.040 |
Why?
| | Ovulation | 1 | 2017 | 1 | 0.040 |
Why?
| | HeLa Cells | 1 | 2017 | 15 | 0.040 |
Why?
| | Aged | 1 | 2018 | 375 | 0.040 |
Why?
| | Mice, Inbred Strains | 1 | 2017 | 5 | 0.040 |
Why?
| | Multigene Family | 1 | 2017 | 7 | 0.040 |
Why?
| | Cell Fusion | 1 | 1997 | 1 | 0.040 |
Why?
| | Homeostasis | 1 | 2017 | 7 | 0.040 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2017 | 11 | 0.040 |
Why?
| | Genetic Predisposition to Disease | 1 | 2018 | 215 | 0.040 |
Why?
| | Astrocytes | 1 | 2017 | 1 | 0.040 |
Why?
| | Choline O-Acetyltransferase | 1 | 2017 | 1 | 0.040 |
Why?
| | Axons | 1 | 2017 | 2 | 0.040 |
Why?
| | Glutamate Decarboxylase | 1 | 2017 | 2 | 0.040 |
Why?
| | Middle Aged | 1 | 2018 | 648 | 0.040 |
Why?
| | Luteinizing Hormone | 1 | 2016 | 1 | 0.040 |
Why?
| | Mifepristone | 1 | 2016 | 2 | 0.040 |
Why?
| | Pregnancy Proteins | 1 | 2016 | 1 | 0.040 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2015 | 8 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2015 | 24 | 0.030 |
Why?
| | RNA, Small Interfering | 1 | 2015 | 19 | 0.030 |
Why?
| | Muscles | 1 | 1995 | 2 | 0.030 |
Why?
| | Luminescent Measurements | 1 | 2014 | 1 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2014 | 26 | 0.030 |
Why?
| | Computational Biology | 1 | 2014 | 40 | 0.030 |
Why?
| | Microinjections | 1 | 2014 | 1 | 0.030 |
Why?
| | Rats, Mutant Strains | 1 | 2014 | 1 | 0.030 |
Why?
| | Zinc Fingers | 1 | 2014 | 2 | 0.030 |
Why?
| | Deoxyribonucleases | 1 | 2014 | 2 | 0.030 |
Why?
| | Protein Engineering | 1 | 2014 | 3 | 0.030 |
Why?
| | Gene Knockout Techniques | 1 | 2014 | 5 | 0.030 |
Why?
| | Codon, Nonsense | 1 | 2014 | 6 | 0.030 |
Why?
| | Blastomeres | 1 | 2012 | 1 | 0.030 |
Why?
| | GATA3 Transcription Factor | 1 | 2012 | 1 | 0.030 |
Why?
| | Blastocyst Inner Cell Mass | 1 | 2012 | 1 | 0.030 |
Why?
| | Green Fluorescent Proteins | 1 | 2012 | 3 | 0.030 |
Why?
| | Cattle | 1 | 2012 | 24 | 0.030 |
Why?
| | Macaca mulatta | 1 | 2012 | 22 | 0.030 |
Why?
| | GATA2 Transcription Factor | 1 | 2010 | 1 | 0.020 |
Why?
| | Hematopoiesis | 1 | 2010 | 3 | 0.020 |
Why?
| | Methylation | 1 | 2010 | 11 | 0.020 |
Why?
| | Trans-Activators | 1 | 2010 | 11 | 0.020 |
Why?
| | Cell Cycle | 1 | 2010 | 14 | 0.020 |
Why?
| | Proto-Oncogene Proteins | 1 | 2010 | 17 | 0.020 |
Why?
| | Hematopoietic Stem Cells | 1 | 2010 | 22 | 0.020 |
Why?
| | Apoptosis | 1 | 2010 | 43 | 0.020 |
Why?
| | Protein Kinase C | 1 | 2008 | 4 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2008 | 14 | 0.020 |
Why?
| | Polyribosomes | 1 | 2007 | 2 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2007 | 2 | 0.020 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2007 | 9 | 0.020 |
Why?
| | RNA-Binding Proteins | 1 | 2007 | 5 | 0.020 |
Why?
| | DNA Primers | 1 | 2007 | 27 | 0.020 |
Why?
| | Ethylnitrosourea | 1 | 2003 | 1 | 0.010 |
Why?
| | Polymorphism, Single-Stranded Conformational | 1 | 2003 | 3 | 0.010 |
Why?
| | Pregnancy Complications | 1 | 2002 | 8 | 0.010 |
Why?
| | Syndrome | 1 | 2002 | 33 | 0.010 |
Why?
| | Analgesics, Opioid | 1 | 2002 | 44 | 0.010 |
Why?
| | Kidney Transplantation | 1 | 2002 | 114 | 0.010 |
Why?
| | Prospective Studies | 1 | 2002 | 508 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2002 | 624 | 0.010 |
Why?
| | Hybrid Cells | 1 | 1997 | 1 | 0.010 |
Why?
| | Chimera | 1 | 1997 | 2 | 0.010 |
Why?
| | beta-Galactosidase | 1 | 1997 | 2 | 0.010 |
Why?
| | Vascular Cell Adhesion Molecule-1 | 1 | 1995 | 1 | 0.010 |
Why?
| | Extremities | 1 | 1995 | 2 | 0.010 |
Why?
| | Histocompatibility Antigens | 1 | 1995 | 2 | 0.010 |
Why?
| | MyoD Protein | 1 | 1995 | 4 | 0.010 |
Why?
| | Mice, Mutant Strains | 1 | 1995 | 7 | 0.010 |
Why?
|
|
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|